Estrogen receptor α gene ESR1 amplification may predict endocrine therapy responsiveness in breast cancer patients

Cancer Science

Volumn 100, Issue 6, 2009, Pages 1012-1017

  Tomita, Saori ^a   Zhang, Zhenhuan ^a   Nakano, Masahiro ^a   Ibusuki, Mutsuko ^a   Kawazoe, Teru ^a   Yamamoto, Yutaka ^a   Iwase, Hirotaka ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; AROMATASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ANTINEOPLASTIC AGENT; ESR1 PROTEIN, HUMAN; PRIMER DNA; RIBONUCLEASE P; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION; GENE NUMBER; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR VOLUME; BREAST TUMOR; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETICS; MENSTRUAL CYCLE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; AROMATASE INHIBITORS; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; DNA PRIMERS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR MODULATORS; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RIBONUCLEASE P;

EID: 67649870743     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01145.x     Document Type: Article

References (36)

1. Ricketts D, Turnbull L, Ryall G. Estrogen and progesterone receptors in the normal female breast. Cancer Res 1991, 51:1817-22.
2. Markopoulos C, Berger U, Wilson P, Gazet JC, Coombes RC. Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle. Br Med J (Clin Res Ed) 1988, 296:1349-51.
3. Allred DC, Mohsin SK, Fuqua SA. Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer 2001, 8:47-61.
4. Herynk MH, Fuqua SA. Estrogen receptor mutations in human disease. Endocr Rev 2004, 25:869-98.
5. Iwase H, Omoto Y, Iwata H. DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancers. Br J Cancer 1999, 80:1982-6.
6. Parrella P, Poeta ML, Gallo AP. Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors. Clin Cancer Res 2004, 10:5349-54.
7. Adams BD, Furneaux H, White BA. The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERα) and represses ERα messenger RNA and protein expression in breast cancer cell lines. Mol Endocrinol 2007, 21:1132-47.
8. Kondo N, Toyama T, Sugiura H, Fujii Y, Yamashita H. miR-206 expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res 2008, 68:5004-8.
9. Zhao JJ, Lin J, Yang H. MicroRNA-221/222 negatively regulates ERalpha and associates with tamoxifen resistance in breast cancer. J Biol Chem 2008, 283:31079-86.
10. Pinkel D, Albertson DG. Array comparative genomic hybridization and its applications in cancer. Nat Genet 2005, 37(Suppl):S11-17.
11. Slamon DJ, Leyland-Jones B, Shak S. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001, 344:783-92.
12. Iwase H, Greenman JM, Barnes DM, Bobrow L, Hodgson S, Mathew CG. Loss of heterozygosity of the oestrogen receptor gene in breast cancer. Br J Cancer 1995, 71:448-50.
13. Nembrot M, Quintana B, Mordoh J. Estrogen receptor gene amplification is found in some estrogen receptor-positive human breast tumors. Biochem Biophys Res Commun 1990, 166:601-7.
14. Schuur ER, Weigel RJ. Monoallelic amplification of estrogen receptor-alpha expression in breast cancer. Cancer Res 2000, 60:2598-601.
15. Holst F, Stahl PR, Ruiz C. Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Nat Genet 2007, 39:655-60.
16. Brown LA, Hoog J, Chin SF. ESR1 gene amplification in breast cancer: a common phenomenon?. Nat Genet 2008, 40:806-7.
17. Horlings HM, Bergamaschi A, Nordgard SH. ESR1 gene amplification in breast cancer: a common phenomenon?. Nat Genet 2008, 40:807-8.
18. Vincent-Salomon A, Raynal V, Lucchesi C, Gruel N, Delattre O. ESR1 gene amplification in breast cancer: a common phenomenon?. Nat Genet 2008, 40:809.
19. Reis-Filho JS, Drury S, Lambros MB. ESR1 gene amplification in breast cancer: a common phenomenon?. Nat Genet 2008, 40:809-10.
20. Adelaide J, Finetti P, Charafe-Jauffret E. Absence of ESR1 amplification in a series of breast cancers. Int J Cancer 2008, 123:2970-2.
21. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 2001, 19:3817-27.
22. Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 2003, 21:3357-65.
23. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thurlimann B, Senn HJ. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol 2005, 16:1569-83.
24. Yamashita H, Nishio M, Toyama T. Coexistence of HER2 over-expression and p53 protein accumulation is a strong prognostic molecular marker in breast cancer. Breast Cancer Res 2004, 6:R24-30.
25. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998, 11:155-68.
26. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235:177-82.
27. Ro J, North SM, Gallick GE, Hortobagyi GN, Gutterman JU, Blick M. Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma. Cancer Res 1988, 48:161-4.
28. Rummukainen JK, Salminen T, Lundin J, Kytola S, Joensuu H, Isola JJ. Amplification of c-myc by fluorescence in situ hybridization in a population-based breast cancer tissue array. Mod Pathol 2001, 14:1030-5.
29. Hui R, Campbell DH, Lee CS. EMS1 amplification can occur independently of CCND1 or INT-2 amplification at 11q13 and may identify different phenotypes in primary breast cancer. Oncogene 1997, 15:1617-23.
30. Courjal F, Cuny M, Rodriguez C. DNA amplifications at 20q13 and MDM2 define distinct subsets of evolved breast and ovarian tumours. Br J Cancer 1996, 74:1984-9.
31. Gray JW, Collins C, Henderson IC. Molecular cytogenetics of human breast cancer. Cold Spring Harb Symp Quant Biol 1994, 59:645-52.
32. Pollack JR, Sorlie T, Perou CM. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 2002, 99:12 963-8.
33. Carter KC, Bowman D, Carrington W. A three-dimensional view of precursor messenger RNA metabolism within the mammalian nucleus. Science 1993, 259:1330-5.
34. Cremer M, von Hase J, Volm T. Non-random radial higher-order chromatin arrangements in nuclei of diploid human cells. Chromosome Res 2001, 9:541-67.
35. Gotta M, Laroche T, Formenton A, Maillet L, Scherthan H, Gasser SM. The clustering of telomeres and colocalization with Rap1, Sir3, and Sir4 proteins in wild-type Saccharomyces cerevisiae. J Cell Biol 1996, 134:1349-63.
36. Hayashi SI, Yamaguchi Y. Estrogen signaling pathway and hormonal therapy. Breast Cancer 2008, 15:256-61.